"Designing Growth Strategies is in our DNA"

Female Sexual Dysfunction Treatment Market Size, Share & Industry Analysis, By Drug (Flibanserin, Bremelanotide, Ospemifene, Estrogen Therapy, and Others), By Disease (Hypoactive Sexual Desire Disorder (HSDD), Dyspareunia, and Others), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI100850

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Diseases - by Key Countries/Sub-regions, 2024
    2. Pipeline Analysis
    3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
    4. Impact of COVID-19 on the Global Market
  5. Global Female Sexual Dysfunction Treatment Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug
      1. Flibanserin
      2. Bremelanotide
      3. Ospemifene
      4. Estrogen Therapy
      5. Others
    2. Market Analysis, Insights and Forecast – By Disease
      1. Hypoactive Sexual Desire Disorder (HSDD)
      2. Dyspareunia
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East and Africa
  6. North America Female Sexual Dysfunction Treatment Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug
      1. Flibanserin
      2. Bremelanotide
      3. Ospemifene
      4. Estrogen Therapy
      5. Others
    2. Market Analysis, Insights and Forecast – By Disease
      1. Hypoactive Sexual Desire Disorder (HSDD)
      2. Dyspareunia
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Rest of Europe
  7. Asia Pacific Female Sexual Dysfunction Treatment Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug
      1. Flibanserin
      2. Bremelanotide
      3. Ospemifene
      4. Estrogen Therapy
      5. Others
    2. Market Analysis, Insights and Forecast – By Disease
      1. Hypoactive Sexual Desire Disorder (HSDD)
      2. Dyspareunia
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  8. Latin America Female Sexual Dysfunction Treatment Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug
      1. Flibanserin
      2. Bremelanotide
      3. Ospemifene
      4. Estrogen Therapy
      5. Others
    2. Market Analysis, Insights and Forecast – By Disease
      1. Hypoactive Sexual Desire Disorder (HSDD)
      2. Dyspareunia
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  9. Middle East & Africa Female Sexual Dysfunction Treatment Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug
      1. Flibanserin
      2. Bremelanotide
      3. Ospemifene
      4. Estrogen Therapy
      5. Others
    2. Market Analysis, Insights and Forecast – By Disease
      1. Hypoactive Sexual Desire Disorder (HSDD)
      2. Dyspareunia
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  10. Competitive Analysis
    1. Global Market Share Analysis (2024)
    2. Company Profiles
      1. Sprout Pharmaceuticals, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. financials (Based on Availability)
      2. Mayne Pharma Group Limited
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. financials (Based on Availability)
      3. Duchesnay Pharmaceutical Group Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. financials (Based on Availability)
      4. PALATIN
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. financials (Based on Availability)
      5. Freya Pharma Solutions B.V.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. financials (Based on Availability)
      6. Acerus Pharmaceuticals Corporation
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. financials (Based on Availability)
      7. Millicent Pharma Ltd. (Endoceutics, Inc.)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. financials (Based on Availability)
      8. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Diseases - by Key Countries/Sub-regions, 2024
    2. Pipeline Analysis
    3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
    4. Impact of COVID-19 on the Global Market
  5. Global Female Sexual Dysfunction Treatment Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug
      1. Flibanserin
      2. Bremelanotide
      3. Ospemifene
      4. Estrogen Therapy
      5. Others
    2. Market Analysis, Insights and Forecast – By Disease
      1. Hypoactive Sexual Desire Disorder (HSDD)
      2. Dyspareunia
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East and Africa
  6. North America Female Sexual Dysfunction Treatment Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug
      1. Flibanserin
      2. Bremelanotide
      3. Ospemifene
      4. Estrogen Therapy
      5. Others
    2. Market Analysis, Insights and Forecast – By Disease
      1. Hypoactive Sexual Desire Disorder (HSDD)
      2. Dyspareunia
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Rest of Europe
  7. Asia Pacific Female Sexual Dysfunction Treatment Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug
      1. Flibanserin
      2. Bremelanotide
      3. Ospemifene
      4. Estrogen Therapy
      5. Others
    2. Market Analysis, Insights and Forecast – By Disease
      1. Hypoactive Sexual Desire Disorder (HSDD)
      2. Dyspareunia
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  8. Latin America Female Sexual Dysfunction Treatment Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug
      1. Flibanserin
      2. Bremelanotide
      3. Ospemifene
      4. Estrogen Therapy
      5. Others
    2. Market Analysis, Insights and Forecast – By Disease
      1. Hypoactive Sexual Desire Disorder (HSDD)
      2. Dyspareunia
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  9. Middle East & Africa Female Sexual Dysfunction Treatment Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug
      1. Flibanserin
      2. Bremelanotide
      3. Ospemifene
      4. Estrogen Therapy
      5. Others
    2. Market Analysis, Insights and Forecast – By Disease
      1. Hypoactive Sexual Desire Disorder (HSDD)
      2. Dyspareunia
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  10. Competitive Analysis
    1. Global Market Share Analysis (2024)
    2. Company Profiles
      1. Sprout Pharmaceuticals, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. financials (Based on Availability)
      2. Mayne Pharma Group Limited
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. financials (Based on Availability)
      3. Duchesnay Pharmaceutical Group Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. financials (Based on Availability)
      4. PALATIN
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. financials (Based on Availability)
      5. Freya Pharma Solutions B.V.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. financials (Based on Availability)
      6. Acerus Pharmaceuticals Corporation
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. financials (Based on Availability)
      7. Millicent Pharma Ltd. (Endoceutics, Inc.)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. financials (Based on Availability)
      8. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. financials (Based on Availability)
Read Less

Figure 1:  Global Female Sexual Dysfunction Treatment Market Revenue Breakdown (USD million, %) by Region, 2025 & 2032

Figure 02: Global Female Sexual Dysfunction Treatment Market Value Share (%), By Drug, 2025 & 2032

Figure 03: Global Female Sexual Dysfunction Treatment Market Value Share (%), By Disease, 2025 & 2032

Figure 04: Global Female Sexual Dysfunction Treatment Market Value Share (%), By Route of Administration, 2025 & 2032

Figure 05: Global Female Sexual Dysfunction Treatment Market Value Share (%), By Distribution Channel, 2025 & 2032

Figure 06: Global Female Sexual Dysfunction Treatment Market Value Share (%), By Region, 2025 & 2032

Figure 07: North America Female Sexual Dysfunction Treatment Market Value (USD million), by Drug, 2025 & 2032

Figure 08: North America Female Sexual Dysfunction Treatment Market Value Share (%), by Drug, 2024

Figure 09: North America Female Sexual Dysfunction Treatment Market Value (USD million), by Disease, 2025 & 2032

Figure 10: North America Female Sexual Dysfunction Treatment Market Value Share (%), by Disease, 2024

Figure 11: North America Female Sexual Dysfunction Treatment Market Value (USD million), by Route of Administration, 2025 & 2032

Figure 12: North America Female Sexual Dysfunction Treatment Market Value Share (%), by Route of Administration, 2024

Figure 13: North America Female Sexual Dysfunction Treatment Market Value (USD million), by Distribution Channel, 2025 & 2032

Figure 14: North America Female Sexual Dysfunction Treatment Market Value Share (%), by Distribution Channel, 2024

Figure 15: North America Female Sexual Dysfunction Treatment Market Value (USD million), by Country/Sub-region, 2025 & 2032

Figure 16: North America Female Sexual Dysfunction Treatment Market Value Share (%), by Country/Sub-region, 2024

Figure 17: Europe Female Sexual Dysfunction Treatment Market Value (USD million), by Drug, 2025 & 2032

Figure 18: Europe Female Sexual Dysfunction Treatment Market Value Share (%), by Drug, 2024

Figure 19: Europe Female Sexual Dysfunction Treatment Market Value (USD million), by Disease, 2025 & 2032

Figure 20: Europe Female Sexual Dysfunction Treatment Market Value Share (%), by Disease, 2024

Figure 21: Europe Female Sexual Dysfunction Treatment Market Value (USD million), by Route of Administration, 2025 & 2032

Figure 22: Europe Female Sexual Dysfunction Treatment Market Value Share (%), by Route of Administration, 2024

Figure 23: Europe Female Sexual Dysfunction Treatment Market Value (USD million), by Distribution Channel, 2025 & 2032

Figure 24: Europe Female Sexual Dysfunction Treatment Market Value Share (%), by Distribution Channel, 2024

Figure 25: Europe Female Sexual Dysfunction Treatment Market Value (USD million), by Country/Sub-region, 2025 & 2032

Figure 26: Europe Female Sexual Dysfunction Treatment Market Value Share (%), by Country/Sub-region, 2024

Figure 27: Asia Pacific Female Sexual Dysfunction Treatment Market Value (USD million), by Drug, 2025 & 2032

Figure 28: Asia Pacific Female Sexual Dysfunction Treatment Market Value Share (%), by Drug, 2024

Figure 29: Asia Pacific Female Sexual Dysfunction Treatment Market Value (USD million), by Disease, 2025 & 2032

Figure 30: Asia Pacific Female Sexual Dysfunction Treatment Market Value Share (%), by Disease, 2024

Figure 31: Asia Pacific Female Sexual Dysfunction Treatment Market Value (USD million), by Route of Administration, 2025 & 2032

Figure 32: Asia Pacific Female Sexual Dysfunction Treatment Market Value Share (%), by Route of Administration, 2024

Figure 33: Asia Pacific Female Sexual Dysfunction Treatment Market Value (USD million), by Distribution Channel, 2025 & 2032

Figure 34: Asia Pacific Female Sexual Dysfunction Treatment Market Value Share (%), by Distribution Channel, 2024

Figure 35: Asia Pacific Female Sexual Dysfunction Treatment Market Value (USD million), by Country/Sub-region, 2025 & 2032

Figure 36: Asia Pacific Female Sexual Dysfunction Treatment Market Value Share (%), by Country/Sub-region, 2024

Figure 37: Rest of the World Female Sexual Dysfunction Treatment Market Value (USD million), by Drug, 2025 & 2032

Figure 38: Rest of the World Female Sexual Dysfunction Treatment Market Value Share (%), by Drug, 2024

Figure 39: Rest of the World Female Sexual Dysfunction Treatment Market Value (USD million), by Disease, 2025 & 2032

Figure 40: Rest of the World Female Sexual Dysfunction Treatment Market Value Share (%), by Disease, 2024

Figure 41: Rest of the World Female Sexual Dysfunction Treatment Market Value (USD million), by Route of Administration, 2025 & 2032

Figure 42: Rest of the World Female Sexual Dysfunction Treatment Market Value Share (%), by Route of Administration, 2024

Figure 43: Rest of the World Female Sexual Dysfunction Treatment Market Value (USD million), by Distribution Channel, 2025 & 2032

Figure 44: Rest of the World Female Sexual Dysfunction Treatment Market Value Share (%), by Distribution Channel, 2024

Figure 45: Global Female Sexual Dysfunction Treatment Market Share (%), By Company, 2024

Table 01: Global Female Sexual Dysfunction Treatment Market Revenue (USD million) Forecast, By Drug, 2019–2032

Table 02: Global Female Sexual Dysfunction Treatment Market Revenue (USD million) Forecast, By Disease, 2019–2032

Table 03: Global Female Sexual Dysfunction Treatment Market Revenue (USD million) Forecast, By Route of Administration, 2019–2032

Table 04: Global Female Sexual Dysfunction Treatment Market Revenue (USD million) Forecast, By Distribution Channel, 2019–2032

Table 05: Global Female Sexual Dysfunction Treatment Market Revenue (USD million) Forecast, By Region, 2019–2032

Table 06: North America Female Sexual Dysfunction Treatment Market Revenue (USD million) Forecast, By Drug, 2019–2032

Table 07: North America Female Sexual Dysfunction Treatment Market Revenue (USD million) Forecast, By Disease, 2019–2032

Table 08: North America Female Sexual Dysfunction Treatment Market Revenue (USD million) Forecast, By Route of Administration, 2019–2032

Table 09: North America Female Sexual Dysfunction Treatment Market Revenue (USD million) Forecast, By Distribution Channel, 2019–2032

Table 10: North America Female Sexual Dysfunction Treatment Market Revenue (USD million) Forecast, By Country/Sub-region, 2019–2032

Table 11: Europe Female Sexual Dysfunction Treatment Market Revenue (USD million) Forecast, By Drug, 2019–2032

Table 12: Europe Female Sexual Dysfunction Treatment Market Revenue (USD million) Forecast, By Disease, 2019–2032

Table 13: Europe Female Sexual Dysfunction Treatment Market Revenue (USD million) Forecast, By Route of Administration, 2019–2032

Table 14: Europe Female Sexual Dysfunction Treatment Market Revenue (USD million) Forecast, By Distribution Channel, 2019–2032

Table 15: Europe Female Sexual Dysfunction Treatment Market Revenue (USD million) Forecast, By Country/Sub-region, 2019–2032

Table 16: Asia Pacific Female Sexual Dysfunction Treatment Market Revenue (USD million) Forecast, By Drug, 2019–2032

Table 17: Asia Pacific Female Sexual Dysfunction Treatment Market Revenue (USD million) Forecast, By Disease, 2019–2032

Table 18: Asia Pacific Female Sexual Dysfunction Treatment Market Revenue (USD million) Forecast, By Route of Administration, 2019–2032

Table 19: Asia Pacific Female Sexual Dysfunction Treatment Market Revenue (USD million) Forecast, By Distribution Channel, 2019–2032

Table 20: Asia Pacific Female Sexual Dysfunction Treatment Market Revenue (USD million) Forecast, By Country/Sub-region, 2019–2032

Table 21: Rest of the World Female Sexual Dysfunction Treatment Market Revenue (USD million) Forecast, By Drug, 2019–2032

Table 22: Rest of the World Female Sexual Dysfunction Treatment Market Revenue (USD million) Forecast, By Disease, 2019–2032

Table 23: Rest of the World Female Sexual Dysfunction Treatment Market Revenue (USD million) Forecast, By Route of Administration, 2019–2032

Table 24: Rest of the World Female Sexual Dysfunction Treatment Market Revenue (USD million) Forecast, By Distribution Channel, 2019–2032

Female Sexual Dysfunction Treatment Market
  • 2019-2032
  • 2024
  • 2019-2023
  • 131
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports